HEADER CYTOKINE/INHIBITOR 19-OCT-09 3KAN TITLE D-DOPACHROME TAUTOMERASE (D-DT)/MACROPHAGE MIGRATION INHIBITORY FACTOR TITLE 2 2 (MIF2) COMPLEXED WITH INHIBITOR 4-IPP COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-DOPACHROME TAUTOMERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: D-DOPACHROME TAUTOMERASE, ISOFORM CRA_B, CDNA FLJ76419, COMPND 5 HIGHLY SIMILAR TO HOMO SAPIENS D-DOPACHROME TAUTOMERASE (DDT), MRNA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL-21; SOURCE 6 GENE: DDT, HCG_41098; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS IMMUNE RESPONSE, CYTOKINE, TAUTOMERASE, CYTOKINE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.ZIEROW,E.LOLIS REVDAT 3 06-SEP-23 3KAN 1 REMARK REVDAT 2 21-OCT-20 3KAN 1 JRNL REMARK LINK REVDAT 1 20-APR-11 3KAN 0 JRNL AUTH D.RAJASEKARAN,S.ZIEROW,M.SYED,R.BUCALA,V.BHANDARI,E.J.LOLIS JRNL TITL TARGETING DISTINCT TAUTOMERASE SITES OF D-DT AND MIF WITH A JRNL TITL 2 SINGLE MOLECULE FOR INHIBITION OF NEUTROPHIL LUNG JRNL TITL 3 RECRUITMENT. JRNL REF FASEB J. V. 28 4961 2014 JRNL REFN ESSN 1530-6860 JRNL PMID 25016026 JRNL DOI 10.1096/FJ.14-256636 REMARK 2 REMARK 2 RESOLUTION. 1.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 114070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.112 REMARK 3 R VALUE (WORKING SET) : 0.112 REMARK 3 FREE R VALUE : 0.129 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2329 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.13 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 8425 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.1180 REMARK 3 BIN FREE R VALUE SET COUNT : 170 REMARK 3 BIN FREE R VALUE : 0.1520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2655 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 496 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 7.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.025 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.025 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.013 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.566 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.975 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2918 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2028 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3988 ; 1.489 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4973 ; 0.974 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 400 ; 6.174 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 117 ;30.852 ;23.504 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 508 ;11.169 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;17.209 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 461 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3290 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 603 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1836 ; 1.201 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 743 ; 0.322 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2981 ; 1.883 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1082 ; 2.672 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 982 ; 3.962 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4946 ; 0.914 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KAN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055756. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 116400 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.130 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.12500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 9.10 REMARK 200 R MERGE FOR SHELL (I) : 0.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.310 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1DPT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CHLORIDE, 0.1 M TRIS PH REMARK 280 8.5, 25% W/V POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 41.64300 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -72.12779 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 83.28600 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -41.64300 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -72.12779 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 41.64300 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 -72.12779 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 193 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 174 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 291 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 164 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB ASP B 72 O HOH B 293 2.04 REMARK 500 NH1 ARG C 13 O HOH C 258 2.07 REMARK 500 NH2 ARG B 74 O HOH B 285 2.13 REMARK 500 OG1 THR B 53 O HOH B 260 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 23 CB CYS B 23 SG -0.178 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 74 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE C 110 45.16 39.66 REMARK 500 THR C 112 -158.19 -135.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RW1 A 120 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 118 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RW1 B 120 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 118 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RW1 C 120 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3B9S RELATED DB: PDB REMARK 900 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) COMPLEXED WITH REMARK 900 INHIBITOR, 4-IPP REMARK 900 RELATED ID: 3B64 RELATED DB: PDB REMARK 900 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FROM LEISHMANIA MAJOR REMARK 900 RELATED ID: 1DPT RELATED DB: PDB REMARK 900 D-DOPACHROME TAUTOMERASE REMARK 900 RELATED ID: 3KER RELATED DB: PDB REMARK 900 D-DOPACHROME TAUTOMERASE (MD-DT)/ MACROPHAGE MIGRATION INHIBITORY REMARK 900 FACTOR 2 (MIF2) COMPLEXED WITH INHIBITOR 4-IPP (MUS MUSCULUS) DBREF 3KAN A 1 117 UNP Q53Y51 Q53Y51_HUMAN 2 118 DBREF 3KAN B 1 117 UNP Q53Y51 Q53Y51_HUMAN 2 118 DBREF 3KAN C 1 117 UNP Q53Y51 Q53Y51_HUMAN 2 118 SEQRES 1 A 117 PRO PHE LEU GLU LEU ASP THR ASN LEU PRO ALA ASN ARG SEQRES 2 A 117 VAL PRO ALA GLY LEU GLU LYS ARG LEU CYS ALA ALA ALA SEQRES 3 A 117 ALA SER ILE LEU GLY LYS PRO ALA ASP ARG VAL ASN VAL SEQRES 4 A 117 THR VAL ARG PRO GLY LEU ALA MET ALA LEU SER GLY SER SEQRES 5 A 117 THR GLU PRO CYS ALA GLN LEU SER ILE SER SER ILE GLY SEQRES 6 A 117 VAL VAL GLY THR ALA GLU ASP ASN ARG SER HIS SER ALA SEQRES 7 A 117 HIS PHE PHE GLU PHE LEU THR LYS GLU LEU ALA LEU GLY SEQRES 8 A 117 GLN ASP ARG ILE LEU ILE ARG PHE PHE PRO LEU GLU SER SEQRES 9 A 117 TRP GLN ILE GLY LYS ILE GLY THR VAL MET THR PHE LEU SEQRES 1 B 117 PRO PHE LEU GLU LEU ASP THR ASN LEU PRO ALA ASN ARG SEQRES 2 B 117 VAL PRO ALA GLY LEU GLU LYS ARG LEU CYS ALA ALA ALA SEQRES 3 B 117 ALA SER ILE LEU GLY LYS PRO ALA ASP ARG VAL ASN VAL SEQRES 4 B 117 THR VAL ARG PRO GLY LEU ALA MET ALA LEU SER GLY SER SEQRES 5 B 117 THR GLU PRO CYS ALA GLN LEU SER ILE SER SER ILE GLY SEQRES 6 B 117 VAL VAL GLY THR ALA GLU ASP ASN ARG SER HIS SER ALA SEQRES 7 B 117 HIS PHE PHE GLU PHE LEU THR LYS GLU LEU ALA LEU GLY SEQRES 8 B 117 GLN ASP ARG ILE LEU ILE ARG PHE PHE PRO LEU GLU SER SEQRES 9 B 117 TRP GLN ILE GLY LYS ILE GLY THR VAL MET THR PHE LEU SEQRES 1 C 117 PRO PHE LEU GLU LEU ASP THR ASN LEU PRO ALA ASN ARG SEQRES 2 C 117 VAL PRO ALA GLY LEU GLU LYS ARG LEU CYS ALA ALA ALA SEQRES 3 C 117 ALA SER ILE LEU GLY LYS PRO ALA ASP ARG VAL ASN VAL SEQRES 4 C 117 THR VAL ARG PRO GLY LEU ALA MET ALA LEU SER GLY SER SEQRES 5 C 117 THR GLU PRO CYS ALA GLN LEU SER ILE SER SER ILE GLY SEQRES 6 C 117 VAL VAL GLY THR ALA GLU ASP ASN ARG SER HIS SER ALA SEQRES 7 C 117 HIS PHE PHE GLU PHE LEU THR LYS GLU LEU ALA LEU GLY SEQRES 8 C 117 GLN ASP ARG ILE LEU ILE ARG PHE PHE PRO LEU GLU SER SEQRES 9 C 117 TRP GLN ILE GLY LYS ILE GLY THR VAL MET THR PHE LEU HET RW1 A 120 12 HET CL A 118 1 HET RW1 B 120 12 HET CL B 118 1 HET RW1 C 120 12 HETNAM RW1 4-PHENYLPYRIMIDINE HETNAM CL CHLORIDE ION HETSYN RW1 6-PHENYLPYRIMIDINE FORMUL 4 RW1 3(C10 H8 N2) FORMUL 5 CL 2(CL 1-) FORMUL 9 HOH *496(H2 O) HELIX 1 1 PRO A 10 VAL A 14 5 5 HELIX 2 2 GLY A 17 GLY A 31 1 15 HELIX 3 3 PRO A 33 VAL A 37 5 5 HELIX 4 4 THR A 69 ALA A 89 1 21 HELIX 5 5 GLY A 91 ASP A 93 5 3 HELIX 6 6 GLU A 103 GLN A 106 5 4 HELIX 7 7 THR A 115 LEU A 117 5 3 HELIX 8 8 PRO B 10 VAL B 14 5 5 HELIX 9 9 GLY B 17 GLY B 31 1 15 HELIX 10 10 PRO B 33 VAL B 37 5 5 HELIX 11 11 THR B 69 ALA B 89 1 21 HELIX 12 12 GLY B 91 ASP B 93 5 3 HELIX 13 13 GLU B 103 GLN B 106 5 4 HELIX 14 14 THR B 115 LEU B 117 5 3 HELIX 15 15 PRO C 10 VAL C 14 5 5 HELIX 16 16 GLY C 17 GLY C 31 1 15 HELIX 17 17 PRO C 33 VAL C 37 5 5 HELIX 18 18 THR C 69 ALA C 89 1 21 HELIX 19 19 GLY C 91 ASP C 93 5 3 HELIX 20 20 GLU C 103 GLN C 106 5 4 HELIX 21 21 THR C 115 LEU C 117 5 3 SHEET 1 A 4 ASN A 38 ARG A 42 0 SHEET 2 A 4 PHE A 2 THR A 7 1 N LEU A 5 O THR A 40 SHEET 3 A 4 ALA A 57 ILE A 64 -1 O SER A 62 N PHE A 2 SHEET 4 A 4 ILE A 95 LEU A 102 1 O PHE A 100 N ILE A 61 SHEET 1 B 2 GLY A 108 LYS A 109 0 SHEET 2 B 2 THR A 112 VAL A 113 -1 O THR A 112 N LYS A 109 SHEET 1 C 4 ASN B 38 ARG B 42 0 SHEET 2 C 4 PHE B 2 THR B 7 1 N LEU B 5 O THR B 40 SHEET 3 C 4 ALA B 57 ILE B 64 -1 O SER B 62 N PHE B 2 SHEET 4 C 4 ILE B 95 LEU B 102 1 O PHE B 100 N ILE B 61 SHEET 1 D 2 GLY B 108 LYS B 109 0 SHEET 2 D 2 THR B 112 VAL B 113 -1 O THR B 112 N LYS B 109 SHEET 1 E 4 ASN C 38 ARG C 42 0 SHEET 2 E 4 PHE C 2 THR C 7 1 N LEU C 5 O THR C 40 SHEET 3 E 4 ALA C 57 ILE C 64 -1 O SER C 62 N PHE C 2 SHEET 4 E 4 ILE C 95 LEU C 102 1 O PHE C 100 N ILE C 61 SHEET 1 F 2 GLY C 108 LYS C 109 0 SHEET 2 F 2 THR C 112 VAL C 113 -1 O THR C 112 N LYS C 109 LINK N PRO A 1 C4 RW1 A 120 1555 1555 1.43 LINK N PRO B 1 C4 RW1 B 120 1555 1555 1.41 LINK N PRO C 1 C4 RW1 C 120 1555 1555 1.47 SITE 1 AC1 8 PRO A 1 PHE A 2 ARG A 36 ASN A 38 SITE 2 AC1 8 LYS A 109 MET A 114 CL A 118 HOH A 213 SITE 1 AC2 6 PRO A 1 LYS A 32 SER A 63 ILE A 64 SITE 2 AC2 6 RW1 A 120 HOH A 273 SITE 1 AC3 7 PRO B 1 PHE B 2 ARG B 36 ASN B 38 SITE 2 AC3 7 MET B 114 CL B 118 HOH B 180 SITE 1 AC4 5 PRO B 1 LYS B 32 SER B 63 ILE B 64 SITE 2 AC4 5 RW1 B 120 SITE 1 AC5 5 PRO C 1 PHE C 2 ARG C 36 ASN C 38 SITE 2 AC5 5 MET C 114 CRYST1 83.286 83.286 40.303 90.00 90.00 120.00 P 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012007 0.006932 0.000000 0.00000 SCALE2 0.000000 0.013864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024812 0.00000